See also this year's filing and all EDGAR filings for this company.
PDF Report 0001560241_2023_G1_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001560241, G1 Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 179,500,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,989,000 |
| 3 | remainder_Assets | 6,476,000 |
| 4 | LiabilitiesCurrent | 35,588,000 |
| 5 | LiabilitiesNoncurrent | 5,615,000 |
| 6 | remainder_Liabilities | 78,015,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 114,834,204 |
| 9 | ResearchAndDevelopmentExpense | 85,530,496 |
| 10 | remainder_Expenses | 17,972,204 |
| 11 | remainder_Revenues | 45,566,332 |
| 12 | remainder_NetIncome | -12,570,929 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 187,965,000 |
| 1 | Liabilities | 119,218,000 |
| 2 | Expenses | 218,336,904 |
| 3 | Revenues | 45,566,332 |
| 4 | StockholdersEquity | 68,747,000 |
| 5 | NetIncome | -185,341,501 |
| 6 | ComprehensiveNetIncome | -185,341,501 |
| 7 | BaseVar | 291,828,582 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.231 |
| 9 | EconomicCapitalRatio | 1.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
